That's the same part that stuck out to me.....things are looking really good !!!
Wouldn't be surprised if Jazz Pharma ends up buying the rights to this drug if it proves to be a better formulation that epidiolex.....Exciting to think about!!!
- Forums
- ASX - By Stock
- EMD
- Ann: Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD
EMD
emyria limited
Add to My Watchlist
2.94%
!
3.5¢

Ann: Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.5¢ |
Change
0.001(2.94%) |
Mkt cap ! $21.40M |
Open | High | Low | Value | Volume |
3.4¢ | 3.5¢ | 3.1¢ | $221.0K | 6.502M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 392668 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.034 |
2 | 208121 | 0.033 |
3 | 425000 | 0.032 |
4 | 669519 | 0.031 |
6 | 451943 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 392668 | 1 |
0.036 | 345713 | 4 |
0.037 | 50000 | 1 |
0.038 | 40000 | 1 |
0.039 | 65533 | 3 |
Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |